Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • maa1024
    Junior Member
    • Jan 2018
    • 2

    #1

    Optimizing a ddRADSeq study with a large genome

    I am designing a study to investigate the population genetic structure of an endangered species. We've decided to go the ddRADSeq route, and I have a few questions for anyone who has experience with this sequencing method and/or population genetics.

    My species has a large genome (~2Gb), and because I'm assessing change across the entirety of North America over a span of 100 years, I also have a large sample size (n=480).

    In order to maintain a higher level of coverage (25x) while also remaining within the current budget, we can only target 0.25% (5 million bases) of the genome.

    I was hoping for some insight on this issue. Although low, is 0.25% (and 5 million bases) of the genome per individual enough to answer questions regarding population genetic structure with that many individuals at that level of coverage? Or would it be prudent to reduce the amount of coverage in order to include more of the genome?

    Relevant points: 1. No reference genome for this species, but there is one for a closely related species. 2. Very little is known about this species and no population genetics study has been conducted to compare to.
  • Gopo
    Member
    • Nov 2013
    • 41

    #2
    If I understand you correctly, your samples could be up to 100 years old? Depending on the source of DNA, the DNA maybe sheared and low molecular weight, making it less amenable to ddRAD. If this is the case, one can do an initial ddRAD with high quality DNA samples and develop probes/baits to capture the variable RAD loci. Such target enrichment/sequence capture of the "RADnome" would be amenable for degraded DNA samples. See https://www.ncbi.nlm.nih.gov/pubmed/27416967 for more details on the idea of capturing the RADnome.

    Comment

    • maa1024
      Junior Member
      • Jan 2018
      • 2

      #3
      Thank you for the suggestion! The age of a few of my samples is a concern, but they do not make up the bulk of my sample size. This is certainly something I should look into either way.

      Do you have any suggestions regarding the balance between sample size, coverage, and percent of genome?

      Comment

      • Gopo
        Member
        • Nov 2013
        • 41

        #4
        Unfortunately, I can't really give too much advice about optimizing. Others on the forum have more experience than I do. I've personally subsampled a dataset of 16 individuals, 4 per population, genotyped at 20,000 SNPs down to ~100 random SNPs and have gotten very similar pairwise FST, observed and expected heterozygosity, allelic richness, and STRUCTURE results between the 20,000 SNP and 100 SNP datasets. But results will definitely vary, especially for species of conservation concern.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
          by SEQadmin2




          NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
          Yesterday, 06:46 AM
        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-28-2026, 09:57 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-28-2026, 09:51 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        71 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...